Population Council's MZC outperforms TFV 1 percent gel in microbicide candidate preclinical study
11/26/2015
MZC microbicide gel demonstrates strong efficacy against HIV and HSV-2 in preclinical study.
Antibody-drug compounds and immunotherapy to treat breast cancer
11/26/2015
To more efficiently treat breast cancer, scientists have been researching molecules that selectively bind to cancer cells and deliver a substance that can kill the tumor cells, for several years.
Scientists identify promising new melanoma drug
11/25/2015
The first-in-class compound halts tumor growth by disrupting protein production.
The silence of the genes
11/25/2015
New insights into genomic imprinting.Research led by Dr. Keiji Tanimoto from the University of Tsukuba, Japan, has brought us closer to understanding the mechanisms underlying the phenomenon of...
Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in the use of engineered T-cell therapy to treat cancer, has announced that it has initiated a study of its affinity enhanced T-cell therapy...
Optimal care for older cancer patients should target relevant HRQOL domains according to EORTC study
11/25/2015
In a paper recently published in the European Journal of Cancer, EORTC researchers identified health related quality of life (HRQOL) components that should be considered as most relevant for...
New study on complete response rates for late-stage cancer
11/25/2015
The researchers reported the results of a meta-analysis of 68 chemotherapy trials for cancer treatment between 2000 and 2006 - before the gradual introduction of targeted cancer therapies (drugs that...
European Commission approves Blincyto for acute lymphoblastic leukemia
11/25/2015
Amgen has announced that the European Commission (EC) has granted conditional marketing authorization for BLINCYTO® (blinatumomab) for the treatment of adults with Philadelphia...
FDA approves Portrazza to treat advanced squamous non-small cell lung cancer
11/25/2015
The U.S. Food and Drug Administration has approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced (metastatic) squamous non-small cell lung...
Combination therapy can prevent cytostatic resistance
11/25/2015
Researchers at Karolinska Institutet in Sweden have found a new way of preventing resistance to cytostatics used in the treatment of cancers such as medulloblastoma, the most common form of...